Maui Derm News: DecisionDx-SCC Improves Risk Stratification Among Patients With SCC Tumors on the Head or Neck When Combined With BWH Staging
Castle Biosciences, Inc.’s DecisionDx-SCC test improves risk stratification of patients with cutaneous squamous cell carcinoma (SCC) tumors located on the head or neck when the test’s results are combined with Brigham and Women’s Hospital (BWH) staging, new research shows. The new study was selected as a late breaker top five finalist for the best poster […]